SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 mL Injection, 5y to < 12y (EUA)
RxNorm 2691200

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2691200 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 mL Injection, 5y to < 12y (EUA).

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
0.3 mL SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.0333 mg/ML Injection
Primary clinical definition
AUI:12909126
View
PSN
SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 mL Injection, 5y to < 12y (EUA)
AUI:12913811
View
SY
SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 mL Injection, 5y to < 12y (EUA)
AUI:12913810
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDPrescribable

Semantic Clinical Drug (SCD):
0.3 mL SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.0333 mg/ML Injection
(Atom ID: 12909126)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.0333 MG/ML Injection
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2691200
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12909126
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
2691200
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{2691198} 2691192
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{2691198} 2691192
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
0.0333 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2))
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{2691198} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXN QUANTITY
0.3 ML
Normal Form quantity factor
PSNPrescribable

Prescribable Name (PSN):
SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 mL Injection, 5y to < 12y (EUA)
(Atom ID: 12913811)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Injection, 5y to < 12y (EUA)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2691200
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12913811
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2691200
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 mL Injection, 5y to < 12y (EUA)
(Atom ID: 12913810)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Injection, 5y to < 12y (EUA)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2691200
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12913810
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2691200
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

COVID-19 Vaccine, mRNA


Why get vaccinated? COVID-19, mRNA vaccine can prevent COVID-19 disease. COVID-19 disease is caused by a coronavirus called SARS-CoV-2. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory (lung) illness, but it can also affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness leading to death. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever, chills, cough, shortness of breath, fatigue, muscle or body aches, headache, loss of taste or smell, sore throat, congestion, runny nose, nausea, vomiting, or diarrhea.
[Learn More]


* Please review the disclaimer below.